Head of Clinical Biomarker Strategy – Oncology

BeiGene, Ltd.; United States; Remote; USD 147.000 - 197.000; Vollzeit

Benefits dieser Stelle

Medical

Dental

Vision

401(k)

FSA/HSA

Life Insurance

Paid Time Off

Wellness

Zusammenfassung

BeOne seeks an Associate Director of Clinical Biomarker & Translational Medicine for Oncology to drive biomarker strategies across solid tumor programs. You will lead cross-functional teams, oversee assay development and validation, and guide regulatory submissions within a dynamic oncology portfolio.

The role demands a PhD/MD-PhD with 5+ years in pharma/biotech biomarker science, strong translational leadership, and Mandarin proficiency, with travel not required.

Qualifikationen

• PhD or MD/PhD in a relevant scientific discipline.
• 5+ years’ experience in pharmaceutical or biotechnology settings, focusing on biomarker science in oncology.
• Deep expertise in biomarker discovery, clinical assay development, and validation.
• Strong leadership in translational medicine with regulatory submission experience.
• Mandarin language proficiency is required.

Aufgaben

• Lead global clinical biomarker strategy for solid tumor oncology in partnership with cross-functional teams.
• Oversee biomarker assay development and validation, including design and analytical/clinical validation.
• Direct analysis and interpretation of biomarker data to inform go/no-go decisions and trial advancement.
• Communicate biomarker data insights and strategy recommendations to stakeholders.
• Serve as scientific leader and SME contributing to program strategy and biomarker publications.
• Manage external partnerships with academic institutions, CROs, and industry partners.
• Contribute to regulatory submissions related to biomarker strategies and companion diagnostics.

Ausbildung

PhD or MD/PhD in a relevant scientific discipline

Jobbeschreibung

BeOne seeks an Associate Director of Clinical Biomarker & Translational Medicine for Oncology to drive biomarker strategies across solid tumor programs. You will lead cross-functional teams, oversee assay development and validation, and guide regulatory submissions within a dynamic oncology portfolio.

The role demands a PhD/MD-PhD with 5+ years in pharma/biotech biomarker science, strong translational leadership, and Mandarin proficiency, with travel not required.